Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × Opdualag × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 6 Recurrence 2 Squamous Cell Carcinoma of Head and Neck 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Central Nervous System Neoplasms 1 Carcinoma, Merkel Cell 1 Carcinoma, Basal Cell 1

Interventions

Nivolumab 4 Specimen Handling 3 Biopsy 3 cemiplimab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 tocilizumab 1 talimogene laherparepvec 1 relatlimab 1 prednylidene 1 poly ICLC 1 pembrolizumab 1 flt3 ligand protein 1 deltacortene 1 daromun 1 Vitamin D 1 Surgical Procedures, Operative 1 Sunscreening Agents 1 Standard of Care 1 Sirolimus 1 Radiotherapy 1 Radiation 1 Prednisone 1 Photochemotherapy 1 Opdualag 1 Niacinamide 1 Mohs Surgery 1 MAPRE1 protein, human 1 Dermoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06624475 2026-02-05

NEON

University of California, San Diego

Phase 2 Recruiting

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡